Current Status of Radiopharmaceutical Therapy

电流(流体) 医学物理学 医学 工程类 电气工程
作者
Sara St. James,Bryan P. Bednarz,Stanley Benedict,Jeffrey Craig Buchsbaum,Yuni K. Dewaraja,Eric C. Frey,Robert F. Hobbs,Joseph J. Grudzinski,Emilie Roncali,George Sgouros,Jacek Capala,Ying Xiao
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:109 (4): 891-901 被引量:136
标识
DOI:10.1016/j.ijrobp.2020.08.035
摘要

In radiopharmaceutical therapy (RPT), a radionuclide is systemically or locally delivered with the goal of targeting and delivering radiation to cancer cells while minimizing radiation exposure to untargeted cells. Examples of current RPTs include thyroid ablation with the administration of 131I, treatment of liver cancer with 90Y microspheres, the treatment of bony metastases with 223Ra, and the treatment of neuroendocrine tumors with 177Lu-DOTATATE. New RPTs are being developed where radionuclides are incorporated into systemic targeted therapies. To assure that RPT is appropriately implemented, advances in targeting need to be matched with advances in quantitative imaging and dosimetry methods. Currently, radiopharmaceutical therapy is administered by intravenous or locoregional injection, and the treatment planning has typically been implemented like chemotherapy, where the activity administered is either fixed or based on a patient’s body weight or body surface area. RPT pharmacokinetics are measurable by quantitative imaging and are known to vary across patients, both in tumors and normal tissues. Therefore, fixed or weight-based activity prescriptions are not currently optimized to deliver a cytotoxic dose to targets while remaining within the tolerance dose of organs at risk. Methods that provide dose estimates to individual patients rather than to reference geometries are needed to assess and adjust the injected RPT dose. Accurate doses to targets and organs at risk will benefit the individual patients and decrease uncertainties in clinical trials. Imaging can be used to measure activity distribution in vivo, and this information can be used to determine patient-specific treatment plans where the dose to the targets and organs at risk can be calculated. The development and adoption of imaging-based dosimetry methods is particularly beneficial in early clinical trials. In this work we discuss dosimetric accuracy needs in modern radiation oncology, uncertainties in the dosimetry in RPT, and best approaches for imaging and dosimetry of internal radionuclide therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
田様的应助被科研通管家采纳,获得10
4秒前
ding的应助被科研通管家采纳,获得10
4秒前
科研通AI65的应助被科研通管家采纳,获得10
4秒前
传奇3的应助被科研通管家采纳,获得10
4秒前
4秒前
luyue9406的应助被科研通管家采纳,获得10
4秒前
霁月发布了新的文献求助10
4秒前
天天快乐的应助被科研通管家采纳,获得10
4秒前
霁月发布了新的文献求助10
4秒前
霁月发布了新的文献求助10
5秒前
Lucas的应助被科研通管家采纳,获得30
5秒前
科研通AI65的应助被科研通管家采纳,获得10
5秒前
李爱国的应助被xy采纳,获得10
5秒前
Youdge的应助被科研通管家采纳,获得20
5秒前
Youdge的应助被科研通管家采纳,获得20
5秒前
天天快乐的应助被科研通管家采纳,获得10
5秒前
SciGPT的应助被科研通管家采纳,获得10
5秒前
Akim的应助被科研通管家采纳,获得10
5秒前
6秒前
科目三的应助被科研通管家采纳,获得10
6秒前
6秒前
糖果悠悠的应助被小红采纳,获得10
6秒前
情怀的应助被科研通管家采纳,获得10
6秒前
Feng的应助被科研通管家采纳,获得20
6秒前
李爱国的应助被科研通管家采纳,获得10
6秒前
共享精神的应助被科研通管家采纳,获得10
6秒前
Lucas的应助被科研通管家采纳,获得10
6秒前
充电宝的应助被科研通管家采纳,获得10
6秒前
烟花的应助被科研通管家采纳,获得10
7秒前
十万毫升硫酸钡完成签到 ,获得积分10
7秒前
852的应助被科研通管家采纳,获得10
7秒前
Youdge的应助被科研通管家采纳,获得10
7秒前
Youdge的应助被科研通管家采纳,获得20
7秒前
繁荣的瑛的应助被科研通管家采纳,获得10
7秒前
小二郎的应助被科研通管家采纳,获得10
7秒前
bkagyin的应助被科研通管家采纳,获得10
7秒前
斯文败类的应助被科研通管家采纳,获得10
7秒前
2799完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187328
求助须知:如何正确求助?哪些是违规求助? 9575427
关于积分的说明 21841244
捐赠科研通 7784994
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559375
邀请新用户注册赠送积分活动 2481820